SEC Filing Details

Document Details

Form

Filing Date

01/10/2023

Document Date

01/09/2023

Form Description

Amendment to a previously filed 8-K

Filing Group

Current Reports

Company

Eagle Pharmaceuticals, Inc.

Issuer

EAGLE PHARMACEUTICALS, INC.

View HTML

XBRL Viewer

Change % Volume Data as of 03/13/2023 9:16 AM EDT Data Provided by Refinitiv. Minimum 15 minutes delayed.

In-Site
Communications, Inc.
Lisa M. Wilson,
212-452-2793

For all other media inquiries, please contact us.